01Approach to the Critical Patient/attcp34

Immediate priorities

›Cannot-miss immediate threats

›DVT exclusion as first priority

›Duplex ultrasound before attributing symptoms to cyst rupture

›DVT and Baker's cyst can coexist in up to 7 of 95 patients in case series

›Posterior compartment syndrome

›Severe pain out of proportion to exam

›Pain with passive toe extension

›Tense calf compartment

›Rare but limb-threatening, especially if anticoagulated

›Pulmonary embolism concern

›New tachycardia, dyspnea, or hypoxia

›Chest pain with leg swelling

›Septic arthritis or infected cyst

›Fever and systemic toxicity

›Erythema and warmth disproportionate to rupture

Escalation triggers

›Escalation and consultation triggers

›Compartment syndrome signs present

›Orthopedic surgery emergent consultation

›Compartment pressure measurement

›Neurovascular compromise

›Foot drop or absent pulses

›Tibial or peroneal nerve distribution deficit

›DVT confirmed on duplex ultrasound

›Anticoagulation initiation decision

›Risk-benefit assessment if cyst rupture also present

›Inability to ambulate with inadequate pain control

02History/hx54

Presenting symptoms

›Classic rupture symptoms

›Acute onset calf pain and swelling

›Sudden pop or tearing sensation behind the knee

›Often precipitated by increased activity or knee flexion

›Posterior knee fullness prior to rupture

›Known Baker's cyst or prior diagnosis

›Stiffness or tightness behind knee

Temporal and contextual features

›Event and timeline

›Acute vs subacute onset

›Acute rupture often within hours of precipitating activity

›Subacute dissection with gradual progression

›Prior episodes of similar calf swelling

›Recurrent rupture pattern

›Prior anticoagulation use for misdiagnosis

Risk factors and associations

›Underlying joint pathology

›Osteoarthritis of the knee

›Most common association, approximately 50% of cases

›Higher Kellgren-Lawrence grades correlate with larger cysts

›Rheumatoid arthritis

›Approximately 20% of Baker's cyst cases

›Inflammatory pathology disproportionately associated with rupture at 66.7%

›Meniscal tears

›Posterior horn medial meniscus tears in 62% of cysts with tears

›Meniscal pathology creates one-way valve effect at joint-bursa communication

›Gout and crystal arthropathies

03Physical Exam/exam57

Vital signs and general

›Hemodynamic and general assessment

›Vital signs typically normal in uncomplicated rupture

›Tachycardia may suggest pain, concurrent PE, or sepsis

›Fever suggests infection or active inflammatory flare

›General appearance

›Distress level and ability to bear weight

›Systemic toxicity signs

Lower extremity inspection

›Visual assessment

›Unilateral calf swelling and erythema

›Ecchymosis tracking distally appearing days after rupture

›May extend to ankle and foot

›Foucher sign (crescent sign)

›Ecchymosis around medial malleolus

›Suggestive of ruptured Baker's cyst

›Calf circumference measurement

›Compare to contralateral side

›Significant asymmetry supports swelling

Popliteal fossa and calf palpation

›Structural assessment

›Popliteal fossa fullness or fluctuance

›Physical exam misses approximately 50% of intact cysts

›Absence does not exclude ruptured cyst

›Posteromedial calf tenderness

›Distribution of dissected fluid

›Homans sign

›Unreliable for DVT or ruptured cyst — not clinically useful

04Differential Diagnosis/ddx43

Life-threatening diagnoses

›Cannot-miss diagnoses

›Deep vein thrombosis

›ICD-10 I80.2

›Clinically indistinguishable from ruptured Baker's cyst

›DVT and Baker's cyst can coexist

›Pulmonary embolism

›ICD-10 I26.9

›Leg swelling with respiratory symptoms

›Consider when tachycardia or hypoxia present

›Posterior compartment syndrome

›ICD-10 M79.A2

›Rare complication of cyst rupture

›Limb-threatening without decompression

›Septic arthritis with infected cyst

›ICD-10 M00.9

›Fever and systemic toxicity

›Requires urgent joint aspiration and antibiotics

Musculoskeletal mimics

›Structural and soft tissue diagnoses

›Gastrocnemius or soleus muscle tear

›Acute onset with activity

›Ecchymosis from hematoma

›History of pop during exertion

›Superficial thrombophlebitis

›Palpable cord along superficial vein

›Erythema following vein course

›Popliteal artery aneurysm

05Laboratory Tests/lt37

Core inflammatory and infection labs

›Initial blood work

›Complete blood count

›Leukocytosis supports infection or inflammatory flare

›Elevated eosinophils rarely relevant

›C-reactive protein and erythrocyte sedimentation rate

›Elevated in both rupture and DVT as inflammatory processes

›Not specific for distinguishing DVT from cyst rupture

›Uric acid level

›If gout suspected as underlying etiology

›May be normal during acute flare

Coagulation and DVT-related testing

›DVT risk assessment labs

›D-dimer

›Elevated in both DVT and ruptured Baker's cyst

›Useful only if negative to help rule out DVT in low pretest probability

›Positive D-dimer requires imaging regardless of Baker's cyst diagnosis

›Coagulation studies

›Prothrombin time and INR if anticoagulation considered

›Thrombophilia workup if unprovoked DVT suspected

Synovial fluid and joint analysis

›Arthrocentesis results

›Cell count and differential

›Greater than 50,000 WBC per mm3 suggests septic arthritis

›2,000 to 50,000 WBC per mm3 suggests inflammatory arthritis

›Crystal analysis under polarized microscopy

›Negatively birefringent needle-shaped crystals confirm gout

›Positively birefringent rhomboid crystals confirm pseudogout

06Diagnostic Tests/dt66

Scoring Systems

›DVT risk stratification

›Wells score for DVT pretest probability

›Baker's cyst as alternative diagnosis reduces score by 2 points

›Score 0 to 1 low probability — D-dimer to rule out

›Score 2 or higher moderate to high probability — proceed to imaging

›ACEP Level B recommendation for Wells score use in DVT evaluation

›Wells score components

›Active cancer plus 1 point

›Paralysis or recent immobilization plus 1 point

›Bedridden greater than 3 days or surgery in past 4 weeks plus 1 point

›Localized tenderness along deep venous system plus 1 point

›Entire leg swollen plus 1 point

›Calf swelling greater than 3 cm compared to contralateral plus 1 point

›Pitting edema plus 1 point

›Collateral superficial veins plus 1 point

›Alternative diagnosis as or more likely than DVT minus 2 points

MRI

›MRI knee role

›Gold standard for anatomic characterization

›Best modality for identifying underlying intra-articular pathology

›Meniscal tears, chondral lesions, ligament injury

›Cyst characterization on MRI

›Located between semimembranosus and medial gastrocnemius tendons

›Fluid signal intensity on T2 sequences

›Ruptured cyst shows irregular margins and surrounding edema

›MRI findings in rupture

›Fluid tracking distally into calf musculature

07Disposition/dispo42

Discharge criteria

›Safe discharge requirements

›DVT excluded by duplex ultrasound

›Venous compressibility confirmed

›No proximal propagation

›Pain adequately controlled

›Able to bear weight with crutches if needed

›Oral analgesics sufficient

›No compartment syndrome features

›Normal neurovascular exam

›No pain out of proportion

›No septic arthritis or infected cyst

›Afebrile with normal inflammatory markers

›Safe home environment and reliable follow-up

›Able to elevate limb

›Return precautions understood

Admission indications

›Criteria for inpatient admission

›Compartment syndrome confirmed or suspected

›Orthopedic surgery consultation urgently

›ICU-level monitoring may be required post-fasciotomy

›Concurrent DVT requiring anticoagulation initiation

›Complex decision-making with cyst rupture coexisting

›Hospitalist or hematology involvement

›Septic arthritis or infected Baker's cyst

›IV antibiotics and urgent orthopedic consultation

›Neurovascular compromise

›Foot drop or vascular ischemia

08Treatment/t83

Acute conservative management

›RICE protocol

›Rest

›Limit weight-bearing to comfort

›Crutches if needed for ambulation

›Ice application

›Ice pack wrapped in cloth to posterior knee and calf

›20 minutes on, 20 minutes off

›Compression

›Elastic wrap from foot to mid-thigh

›Monitor for increased pain suggesting compartment compression

›Elevation

›Limb above level of heart when resting

›Reduces edema and promotes resorption

Analgesia and anti-inflammatory therapy

›First-line analgesics

›NSAIDs for pain and inflammation

›Ibuprofen 400 to 600 mg orally every 6 to 8 hours with food

›Maximum 2400 mg per day

›Assess renal function before prescribing

›Naproxen 500 mg orally every 12 hours

›Maximum 1000 mg per day

›Preferred in older adults for once or twice daily dosing

›Acetaminophen as adjunct

›500 to 1000 mg orally every 6 hours

›Maximum 4000 mg per day in healthy adults

›Preferred when NSAIDs contraindicated

›Opioids for severe pain

›Short-term use only when NSAID and acetaminophen insufficient

›Avoid in ambulatory patients where possible

Intra-articular and cyst intervention

›Corticosteroid injection

›Intra-articular or intracystic corticosteroid injection

›Triamcinolone acetonide 40 mg with local anesthetic

›Ultrasound guidance improves accuracy

›Significant improvement in WOMAC scores demonstrated (48.6 to 17.2, p less than 0.0001)

›Methylprednisolone acetate 40 to 80 mg as alternative

›Injection outcomes

›Recurrence rate after aspiration and injection alone approximately 12.7%

›Addressing underlying joint pathology reduces recurrence

›Aspiration of cyst or fluid collection

›Ultrasound-guided aspiration

›Up to 280 mL removed in reported cases

›Reduces tension and pain acutely

›Diagnostic and therapeutic simultaneously

Anticoagulation decisions

›Anticoagulation considerations

›Avoid anticoagulation unless DVT is confirmed on imaging

›Inappropriate anticoagulation can worsen fluid dissection

›Can precipitate posterior compartment syndrome

›If DVT confirmed with coexisting cyst rupture

›Standard DVT anticoagulation indicated

›Close monitoring for compartment syndrome signs

›Orthopedic surgery awareness if anticoagulating

›If patient on anticoagulation for other indication

›Careful risk-benefit assessment

›Avoid dose escalation without confirmed DVT

Compression and supportive measures

›Subacute supportive management

›Compression stockings

›Graduated compression 20 to 30 mmHg for persistent swelling

›Applied from foot to knee

›Physical therapy referral

›Quadriceps strengthening after acute phase

›Range of motion exercises when pain allows

Surgical treatment

›Surgical indications

›Arthroscopic internal drainage

›Enlargement of joint-bursa communication

›Addresses underlying one-way valve mechanism

›Lower recurrence than aspiration alone when combined with intra-articular pathology treatment

›Open surgical excision

›Posteromedial approach to cyst

›Reserved for failed conservative management

›Higher recurrence if underlying joint pathology not addressed simultaneously

›Fasciotomy for compartment syndrome

›Emergency surgical decompression

›All four compartments of lower leg may require release

Treatment of underlying pathology

›Address root cause to prevent recurrence

›Meniscal tear repair or partial meniscectomy

›Most common correctable underlying cause

›Arthroscopic approach preferred

›Osteoarthritis management

›Intra-articular hyaluronic acid

›Total knee arthroplasty in advanced disease

›Inflammatory arthritis disease-modifying therapy

›DMARDs for rheumatoid arthritis

›Biologics for refractory inflammatory disease

›Urate-lowering therapy for gout

09Special Populations/sp55

Pregnancy

›Pregnancy-specific considerations

›Physiologic changes affecting presentation

›Increased blood volume and venous pressure

›DVT risk 4 to 5 times higher during pregnancy

›Higher index of suspicion required for DVT exclusion

›Imaging approach in pregnancy

›Ultrasound is preferred and safe in all trimesters

›Avoid CT unless life-threatening indication

›MRI without gadolinium is safe if ultrasound insufficient

›Medication safety

›NSAIDs contraindicated after 20 weeks gestation

›Risk of premature closure of ductus arteriosus

›Acetaminophen is first-line analgesic throughout pregnancy

›Corticosteroid injection generally considered acceptable with obstetric team awareness

›If DVT confirmed during pregnancy

›Low molecular weight heparin preferred over warfarin

›Direct oral anticoagulants contraindicated in pregnancy

Geriatric

›Older adult-specific features

›Higher prevalence of underlying pathology

›Osteoarthritis present in majority of older adults with Baker's cyst

›Polypharmacy and comorbidities complicate management

›NSAID risks in older adults

›Increased GI bleeding risk

›Renal function decline with chronic NSAID use

›Cardiovascular risk assessment required

›Proton pump inhibitor co-prescription when NSAIDs used

10Background/b56

Epidemiology

›Prevalence and demographics

›Prevalence in general adult population approximately 4 to 19%

›Increases significantly after age 50

›Male predominance in some series

›Association with underlying joint pathology

›Osteoarthritis in approximately 50% of adult cases

›Rheumatoid arthritis in approximately 20% of cases

›Meniscal tears in high proportion of athletic populations

›Gout and crystal arthropathies in 13.9% of cases

›Rupture rates

›Rupture more common in inflammatory arthritis than degenerative disease

›Inflammatory arthritis associated with rupture in 66.7% versus lower rates in OA

›DVT misdiagnosis history

›Historically up to 73% of ruptured Baker's cysts led to inappropriate anticoagulation

›Pseudothrombophlebitis syndrome coined to describe clinical overlap

Pathophysiology

›Cyst formation mechanism

›Gastrocnemio-semimembranosus bursa origin

›Bursa located between semimembranosus and medial gastrocnemius tendons

›Communicates with joint space via one-way valve mechanism in adults

›Intra-articular pressure drives fluid into bursa

›One-way valve mechanism

›Posterior capsule acts as valve allowing fluid from joint to bursa

›Fluid cannot return to joint under pressure

›Progressive distension with repeated joint effusion

›Rupture mechanism

›Increased intra-articular pressure with activity or flexion

11Patient Discharge Instructions/pdi29

copy discharge instructions

›Baker's cyst rupture home care

›Rest and limit activity for the next several days

›Use crutches if walking is painful

›Ice the back of the knee and calf

›20 minutes on, 20 minutes off, several times a day

›Compress the calf with an elastic bandage

›Wrap from foot to just below the knee

›Remove if pain increases or foot becomes numb

›Elevate the leg above heart level when resting

›Medications

›Take anti-inflammatory medication as prescribed with food

›Ibuprofen or naproxen for pain and swelling

›Do not start any blood thinners unless specifically prescribed for confirmed blood clot

›What to expect

›Calf pain and swelling typically improve over 1 to 3 weeks

›Bruising around the ankle may appear in the first few days

›Full resolution may take several weeks

›Return to emergency immediately for

›Severe worsening pain especially with moving your toes or ankle

›May indicate a compartment syndrome

›Foot or toes becoming numb, tingly, or weak

›Foot becoming pale, cold, or blue

›Shortness of breath or chest pain

›Fever greater than 38.5 degrees Celsius

›Rapidly increasing swelling or redness

›Follow-up

›See your family doctor or orthopedic specialist within 1 to 2 weeks

12References/r19

Guidelines and key sources

›Primary references

›Brady HR, Quigley C, Stafford FJ et al. Popliteal Cyst Rupture and the Pseudothrombophlebitis Syndrome. Annals of Emergency Medicine. 1987. PMID 3310762

›Anand SS, Wells PS, Hunt D et al. Does This Patient Have Deep Vein Thrombosis? JAMA. 1998. Vol 279(14). PMID 9546567

›Langsfeld M, Matteson B, Johnson W et al. Baker's Cysts Mimicking the Symptoms of Deep Vein Thrombosis: Diagnosis With Venous Duplex Scanning. Journal of Vascular Surgery. 1997. PMID 9129621

Key studies and systematic reviews

›Imaging and diagnosis studies

›Ward EE, Jacobson JA, Fessell DP et al. Sonographic Detection of Baker's Cysts: Comparison With MR Imaging. AJR. 2001. PMID 11159077

›Miller TT, Staron RB, Koenigsberg T et al. MR Imaging of Baker Cysts: Association With Internal Derangement, Effusion, and Degenerative Arthropathy. Radiology. 1996. PMID 8816552

›Torreggiani WC, Al-Ismail K, Munk PL et al. The Imaging Spectrum of Baker's (Popliteal) Cysts. Clinical Radiology. 2002. PMID 12169279

›Treatment studies

›Smith MK, Lesniak B, Baraga MG et al. Treatment of Popliteal (Baker) Cysts With Ultrasound-Guided Aspiration, Fenestration, and Injection: Long-Term Follow-Up. Sports Health. 2015. PMID 26502415

›Van Nest DS, Tjoumakaris FP, Smith BJ et al. Popliteal Cysts: A Systematic Review of Nonoperative and Operative Treatment. JBJS Reviews. 2020. PMID 32149934

›Su C, Kuang SD, Zhao X et al. Clinical Outcome of Arthroscopic Internal Drainage of Popliteal Cysts. BMC Musculoskeletal Disorders. 2020. PMID 32631287

Complication and special topic references

›Complications

›Petros DP, Hanley JF, Gilbreath P, Toon RD. Posterior Compartment Syndrome Following Ruptured Baker's Cyst. Annals of the Rheumatic Diseases. 1990. PMID 2256746

›Sanchez JE, Conkling N, Labropoulos N. Compression Syndromes of the Popliteal Neurovascular Bundle Due to Baker Cyst. Journal of Vascular Surgery. 2011. PMID 21958564

›Coding references

›ICD-10 M71.20 Synovial cyst of popliteal space (Baker's cyst) unspecified knee

›ICD-10 M71.21 Baker's cyst right knee

›ICD-10 M71.22 Baker's cyst left knee

Evidence & Review

Evidence & Review